Cargando…
Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial
We examined the safety and efficacy of human umbilical cord mesenchymal stem cell (hUC-MSC) infusion for immune non-responder (INR) patients with chronic HIV-1 infection, who represent an unmet medical need even in the era of efficient antiretroviral therapy (ART). Seventy-two INR patients with HIV...
Autores principales: | Wang, Lifeng, Zhang, Zheng, Xu, Ruonan, Wang, Xicheng, Shu, Zhanjun, Chen, Xiejie, Wang, Siyu, Liu, Jiaye, Li, Yuanyuan, Wang, Li, Zhang, Mi, Yang, Wei, Wang, Ying, Huang, Huihuang, Tu, Bo, Liang, Zhiwei, Li, Linghua, Li, Jingxin, Hou, Yuying, Shi, Ming, Wang, Fu-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187429/ https://www.ncbi.nlm.nih.gov/pubmed/34103473 http://dx.doi.org/10.1038/s41392-021-00607-2 |
Ejemplares similares
-
The Association of TLR2, TLR3, and TLR9 Gene Polymorphisms With Susceptibility to Talaromycosis Among Han Chinese AIDS Patients in Guangdong
por: Wang, Min, et al.
Publicado: (2021) -
High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study
por: Liu, Jiaye, et al.
Publicado: (2021) -
The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023) -
Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome
por: Chen, Xiaoman, et al.
Publicado: (2022) -
Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial
por: Yang, Yuanjun, et al.
Publicado: (2022)